ReviewPublished 12 October 2026Chimeric antigen receptor-engineered cell therapy for asthma: advances in targeting type 2 inflammation and translational challengesYifei Niu · Chenyang Jian · Peize Liu · Mengwei Wu · Haoyuan Li · Xu Li · Lili ZhiFrontiers in Immunologydoi 10.3389/fimmu.2026.1979396